FIELD: medicine, rheumatology, pharmacy.
SUBSTANCE: invention proposes ointment as a curative agent that comprises the following components: 5-amino-2,3-dihydro-1,4-phthalazinedione alkaline salt of mixture of alkaline salts, medicinal vaseline, vaseline oil as an ointment base and distilled water taken in the following ratio of components, wt.-%: 5-amino-2,3-dihydro-1,4-phthalazinedione alkaline salt or 5-amino-2,3-dihydro-1,4-phthalazinedione mixture of alkaline salts, 1.0-50.0; medicinal vaseline, 10.0-20.0; vaseline oil, 5.0-10.0, and water, the balance, wherein 5-amino-2,3-dihydro-1,4-phthalazinedione sodium or potassium salt is used as an alkaline salt, and 5-amino-2,3-dihydro-1,4-phthalazinedione sodium and potassium salts mixture is used as mixture of alkaline salts composed of the equal ratio of components, i. e. 5-amino-2,3-dihydro-1,4-phthalazinedione sodium and potassium salts mixture. Indicated ointment normalizes membrane cell to the normal state damaged as result of disease, regulated intra- and intercellular metabolic processes that, in turn, promotes to normalization of metabolism and arresting inflammation for the shortest times. Invention can be used in treatment of autoimmune disease.
EFFECT: improved and valuable medicinal properties of ointment.
3 ex
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS, EYE OINTMENT AND METHOD FOR TREATMENT OF OPHTHALMOLOGY DISEASES | 2003 |
|
RU2245138C1 |
MEDICINAL PREPARATION | 2003 |
|
RU2238730C1 |
MEDICINAL PREPARATION (VARIANTS) AND METHOD FOR ITS PRODUCING | 2003 |
|
RU2233161C1 |
INHALATION PREPARATION IN TREATMENT OF TUBERCULOSIS | 2003 |
|
RU2266119C2 |
MEDICINAL PREPARATION (VARIANTS) | 2003 |
|
RU2302863C2 |
MEDICINAL PREPARATION (VARIANTS) AND METHOD FOR ITS PRODUCTION | 2001 |
|
RU2211036C2 |
PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATORY, IMMUNOCORRECTING, IMMUNOSUPPRESSIVE, ANTIVIRAL, ANTI-INFLAMMATORY AND ONCOLYTIC ACTIVITIES | 2021 |
|
RU2775008C1 |
METHOD FOR PREPARING MEDICINAL PREPARATION | 2002 |
|
RU2222327C2 |
METHOD OF OBTAINING MEDICATION | 2010 |
|
RU2439063C1 |
AGENT FOR TREATMENT OF ARTICULATION DISEASES | 2004 |
|
RU2260432C1 |
Authors
Dates
2005-12-20—Published
2003-10-21—Filed